• Logo for the event

    Hybrid Event for Northern New Englanders: Addressing the Intersection of Pain Management and Opioid Use, September 29, 2023

    The New England Opioid Response Network and Northeast Node of the National Drug Abuse Treatment Clinical Trials Network are pleased to bring together experts in the fields of pain and opioid use at a Regional Summit to be held in Concord, New Hampshire, on Friday, September 29, 2023. This event is intended for Northern New England audiences (Maine, New Hampshire, and Vermont). We invite all who provide care to patients that experience pain (acute or chronic), use opioids, or have opioid use disorder, to attend. This interdisciplinary team-based training will provide evidence-based solutions to managing pain and opioid use. In-person attendance is encouraged but limited – register now to reserve your seat!…

  • NIDA HIV Research Program

    NIDA HIV Research Program Seminars, September and October 2023

    Please join the NIDA HIV Research Program (HRP)  for more thought-provoking events coming this fall. First, on Wednesday, September 20, 2023 from 1:00pm to 4:00pm, we are holding a symposium led by recipients of Avenir Award Program (DP2) grants (PAR-23-125). Topics include the effects of opioids on HIV persistence across tissues, rethinking how we collect information to reduce overdose deaths, HIV and substance use comorbidity, developing IFN-modulated vaccines and vulnerabilities of HIV-1 escape from neutralizing antibodies. You can find more detailed information and the Avenir speaker’s list here. Registration is now open. Then, on Wednesday, October 25 at 11:00 a.m. EST we continue our NIDA HIV Seminar Series with the presentation “Long-Acting ART…

  • September webinar 2023

    Webinar: Not Too Much, Not Too Often, and Not Too Many: The Results of the First Large-Scale International Project to Develop Lower-Risk Gambling Guidelines (September 6, 11am PT)

    September 6, 2023 | 11:00am-12:30pm PT | Register here! Advice about how to gamble “responsibly” is widely promoted in many jurisdictions. However, until now, there has been no evidence-based, specific advice for people who gamble who want to reduce their risk of gambling harms. In 2016, the Canadian Centre on Substance Use and Addiction began the first large scale international, comprehensive, multimodal project to develop evidence based Lower-Risk Gambling Guidelines (LRGGs). Borrowing the same collaborative, evidence-driven approach used to develop the nation’s Low Risk Alcohol Drinking Guidelines, the LRGG initiative produced a set of workable, evidence-based quantitative limits on gambling behavior to help people make informed decisions about their gambling.…

  • 2023 D&I: Call for Abstracts

    Science of D&I Conference: Call for Abstracts Open

    AcademyHealth and the National Institutes of Health are once again convening the growing D&I science community for the 16th Annual Conference on the Science of Dissemination and Implementation in Health. The 16th Annual Conference theme is “Raising Expectations for D&I Science: Challenges and Opportunities”. The abstract solicitation and conference structure have been designed to focus our thinking and discussion on the highest priorities for dissemination and implementation science now and in the future to help optimize health and health care in the U.S. and globally. Does this sound like your work? Submit your abstract today! Abstracts due by July 18, 2023, at 5pm ET! Posted June 16, 2023

  • NIDA HIV Seminar Series

    NIDA HIV Seminar Series: Ending the HIV Epidemic in the U.S. (July 26, 1pm ET)

    Join the NIDA HIV Research Program in welcoming Bohdan Nosyk, PhD, Associate Professor and St. Paul’s Hospital CANFAR Chair in HIV/AIDS Research at Simon Fraser University, for the next installment of the NIDA HIV Seminar Series titled “Ending the HIV/AIDS Epidemic in the US: How Do We Intervene to Meet Our Ambitious Goals?” Bohdan Nosyk is an Associate Professor and St. Paul’s Hospital CANFAR Chair in HIV/AIDS Research at the Faculty of Health Sciences, and leads the Health Economic Research Unit at the Center for Health Evaluation & Outcome Sciences. Dr. Nosyk’s research seeks to inform complex policy decisions surrounding the prevention and management of HIV/AIDS and substance use disorders.…

  • TxSUS 2023: Connecting Texas to Accelerate Access

    Big South/West Node Workshop at TxSUS 2023

    The PIs of the CTN Big South/West Node attended this year’s Texas Substance Use Symposium (TxSUS) for a panel titled, “Screening, Interventions and Collaborative Care Models for Increasing SUD Treatment in Primary Care.” The panel session provided an overview and rationale of establishing primary care models for screening and interventions for SUD. The main objectives were to learn about (1) approaches for incorporating alcohol and drug screening into primary care practices, integrated with the electronic health record (EHR); (2) lessons learned from SUD collaborative care trials in primary care settings; and (3) establishing collaborative care models in Federally Qualified Health Centers (FQHC), including pharmacists, in SUD/OUD treatment and management. Find…

  • Greater Intermountain Node: Upcoming Webinar

    Webinar: The Greater Intermountain Node (GIN): Where We Were, Where We Are, and Where We Will Be (April 18, 12pm MT)

    Presenter: Adam J. Gordon, MD, MPH, FACP, DFASAMApril 18, 2023 | 12:00-1:00 PM MST In this presentation, Dr. Gordon will describe the origination, present status, and future opportunities of the CTN Greater Intermountain Node (GIN). He will describe the mission and aims of GIN, as well as the three studies originating from the Node and six studies hosted by it. Dr. Gordon will emphasize the remarkable research and clinical collaboration across the University of Utah campus and greater Intermountain area. He will also discuss the robust mentored training of the GIN and look forward to how the GIN will evolve in the future. Connection information: Zoom ID: 931 8327 3330,…

  • CTN Youth SIG: Upcoming webinar

    CTN Youth SIG Webinar: Getting Evidence-Based Treatments to Youth and Families Who are Involved in the Juvenile Legal System (May 19, 11am ET)

    The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: Getting Evidence-Based Treatments to Youth and Families Who are Involved in the Juvenile Legal System Ashli J. Sheidow, PhD, Senior Research Scientist, Oregon Social Learning CenterFriday, May 19th, 2023 (11:00 a.m.–12:00 p.m. ET) Dr. Sheidow’s services research examines methods and tools for getting substance use interventions to youth with juvenile legal system involvement. She will present lessons learned, with a focus on a task-shifting study with juvenile probation officers delivering contingency management treatment to youth and their parents/caregivers. The presentation will include insights into training and support for different providers, as well as lessons learned about services research design…

  • Young woman looking at laptop and smiling

    Recording Available: Cultural Considerations for Addiction Research: Looking to the Past to Inform the Future

    The Office of Research Training, Diversity, and Disparities is offering a series titled Profiles of Excellence: Focus on Diversity. This webinar, held on March 6, 2023 from 4-5pm EST, featured Ayana Jordan, MD, PhD, of NYU Grossman School of Medicine, talking about “Cultural Considerations for Addiction Research: Looking to the Past to Inform the Future.” View the recording here. (Passcode: Yyr!6b?j)

  • Science Series logo repeating title, speaker, and description from text.

    Webinar: Injectable XR Buprenorphine: A Better Mousetrap or a Paradigm Shift in MOUD (April 6, Northeast Node)

    Join the CTN Northeast Node on April 6, 2023 (12pm-1pm ET) for the latest in their Science Series:  Injectable XR Buprenorphine: A Better Mousetrap or a Paradigm Shift in MOUD? with Eva Quirion, NP, PhD This presentation will explore the science behind extended release (XR) buprenorphine and field experiences in the use of XR buprenorphine in a primary care setting. This talk will also address ways to bring this medication to patients and if this treatment makes financial sense.  1.0 AMA PRA Category 1 CME available! Join the Zoom meeting here (no registration necessary)